Newsroom

WATSONVILLE, Calif.--(BUSINESS WIRE)--Granite (NYSE: GVA) today announced that it has completed the acquisition of Kenny Seng Construction, strengthening Granite’s vertically-integrated construction and construction materials platform in Utah. Acquisition Highlights Expands Granite’s vertically-integrated home market in Utah, enhancing its construction and materials presence in a high-growth region. Adds end-to-end construction capabilities, including earthwork and site preparation, concrete wo...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 24.04.2026 FKU IE00B8X9NZ57 209,100.00 GBP 8,758,538.26 41.887  ...

MENTOR, Ohio--(BUSINESS WIRE)--Avery Dennison Announces Strategic $75 Million Investment in Wiliot to Scale Physical AI...

MUMBAI, Indien & JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (zusammen mit seinen Tochtergesellschaften und/oder verbundenen Unternehmen „Sun Pharma“) und Organon & Co. (NYSE: OGN) („Organon“) gaben heute bekannt, dass sie eine endgültige Vereinbarung geschlossen haben, wonach Sun Pharma alle ausstehenden Aktien von Organon für 14,00 US-Dollar pro Aktie im Rahmen einer reinen Bartransaktion mit...

MUMBAI, India e JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (insieme alle sue aziende controllate e/o associate, “Sun Pharma”) e Organon & Co. (NYSE: OGN) (“Organon”) oggi ha annunciato di aver stretto un accordo definitivo che prevede l'acquisto da parte di Sun Pharma di tutte le azioni rimaste di Organon al costo di 14,00 dollari l'una in una transazione in contanti basata su una valutazione a...

MUMBAI, India & JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (samen met zijn dochterondernemingen en/of geassocieerde ondernemingen, “Sun Pharma”) en Organon & Co. (NYSE: OGN) (“Organon”) hebben vandaag bekendgemaakt dat zij een definitieve overeenkomst hebben gesloten, waarbij Sun Pharma alle uitstaande aandelen van Organon zal verwerven voor US$ 14,00 dollar per aandeel. De transactie vindt vol...

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Summer Road LLC (“Summer Road” or “we”), the beneficial owner of approximately 3% of the outstanding shares of Class A common stock of Ingles Markets, Incorporated (NASDAQ: IMKTA) (“Ingles” or the “Company”), today issued the following open letter to shareholders seeking their support for the election of Rory A. Held to Ingles’ Board of Directors (the “Board”) at the 2026 Annual Meeting of Shareholders. *** Fellow Shareholders, We greatly appreciate the d...

WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust (“REIT”) focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, today announced its results of operations for the quarter ended March 31, 2026. Highlights for the Quarter Ended March 31, 2026: Net income of $1.4 million, or $0.03 per share on...

印度孟买、新泽西州泽西市--(BUSINESS WIRE)--(美国商业资讯)-- Sun Pharmaceutical Industries Limited（Reuters：SUN.BO，Bloomberg：SUNP IN，NSE：SUNPHARMA，BSE：524715） （连同其子公司和/或关联公司，统称“Sun Pharma”）与Organon & Co.（NYSE：OGN）（“Organon”）今日宣布，双方已签署最终协议，根据该协议，Sun Pharma将以每股14.00美元的全现金交易方式收购Organon所有流通股，此次交易的企业估值为117.5亿美元。 Organon是一家跨国医疗保健公司，于2021年从Merck分拆成立，在美国和加拿大以外地区称为MSD。Organon在医疗保健专业人员、患者、监管机构及其他利益相关者中拥有深厚的信任基础和强大的品牌价值。作为女性健康领域的全球领导者，公司的产品组合涵盖女性健康及普药（包括生物类似药）领域的70余种产品，已在全球140个国家上市，其中美国、欧洲、中国、加拿大和巴西是其最大的市场。这一全球业务布局依托于分布在欧...

Mumbai, Índia e Jersey City, Nova Jersey--(BUSINESS WIRE)--A Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (em conjunto com suas subsidiárias e/ou empresas associadas, “Sun Pharma”) e a Organon & Co. (NYSE: OGN) (“Organon”) anunciaram hoje a assinatura de um acordo definitivo pelo qual a Sun Pharma adquirirá todas as ações em circulação da Organon por US$ 14,00 por ação, em uma transação totalmente em dinheiro, com uma avaliação da...